A new psychiatric journal called Clinical Schizophrenia is launching in April that will have a novel distribution policy.
If you’re in the top 70% of antipsychotic drug prescribers in America, you’ll get your copy free.
The journal is intending to publish prestigious studies on the treatment of schizophrenia.
So it not only acts as an incentive to prescribe drugs to patients, it also guarantees that the advertisers (i.e. drug companies) will reach the doctors spending the most money on medication.
Someone got a promotion for that idea I’m sure.